ROIV Roivant Sciences Ltd

USD 11.97 +0.40 ( +3.46)%
Icon

Roivant Sciences Ltd (ROIV) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 11.97

+0.40 (+3.46)%

USD 8.62B

8.15M

USD 18.07(+50.97%)

N/A

Icon

ROIV

Roivant Sciences Ltd (USD)
COMMON STOCK | NSD
USD 11.97
+0.40 ( +3.46)%
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 8.62B

N/A

USD 11.97

Roivant Sciences Ltd (ROIV) Stock Forecast

Show ratings and price targets of :
USD 18.07
(+50.97%)

Based on the Roivant Sciences Ltd stock forecast from 5 analysts, the average analyst target price for Roivant Sciences Ltd is USD 18.07 over the next 12 months. Roivant Sciences Ltd’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Roivant Sciences Ltd is Bullish , which is based on 8 positive signals and 2 negative signals. At the last closing, Roivant Sciences Ltd’s stock price was USD 11.97. Roivant Sciences Ltd’s stock price has changed by -1.07% over the past week, -4.47% over the past month and +9.92% over the last year.

No recent analyst target price found for Roivant Sciences Ltd
No recent average analyst rating found for Roivant Sciences Ltd

Company Overview Roivant Sciences Ltd

Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on bi...Read More

https://roivant.com

50 Broadway, London, United Kingdom, SW1H 0DB

908

March

USD

United States

Adjusted Closing Price for Roivant Sciences Ltd (ROIV)

Loading...

Unadjusted Closing Price for Roivant Sciences Ltd (ROIV)

Loading...

Share Trading Volume for Roivant Sciences Ltd Shares

Loading...

Compare Performance of Roivant Sciences Ltd Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ROIV

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Roivant Sciences Ltd (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +8.00 (+2.01%) USD120.60B 32.57 223.64

Frequently Asked Questions About Roivant Sciences Ltd (ROIV) Stock

Based on ratings from 5 analysts Roivant Sciences Ltd's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 6 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on ROIV's stock to indicate if its a good dividend stock.

Based on targets from 5 analysts, the average taret price for ROIV is USD 18.07 over the next 12 months. The maximum analyst target price is USD 22 while the minimum anlayst target price is USD 12.5.

ROIV stock's Price/Earning ratio is 2.14. Our analysis grades ROIV stock's Price / Earning ratio at D-. This means that ROIV stock's Price/Earning ratio is above 39% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ROIV may be fairly valued for its sector

The last closing price of ROIV's stock was USD 11.97.

The most recent market capitalization for ROIV is USD 8.62B.

Based on targets from 5 analysts, the average taret price for ROIV is projected at USD 18.07 over the next 12 months. This means that ROIV's stock price may go up by +50.97% over the next 12 months.

We can't find any ETFs which contains Roivant Sciences Ltd's stock.

As per our most recent records Roivant Sciences Ltd has 908 Employees.

Roivant Sciences Ltd's registered address is 50 Broadway, London, United Kingdom, SW1H 0DB. You can get more information about it from Roivant Sciences Ltd's website at https://roivant.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Roivant Sciences Ltd (ROIV) Stock

Based on ratings from 5 analysts Roivant Sciences Ltd's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 6 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on ROIV's stock to indicate if its a good dividend stock.

Based on targets from 5 analysts, the average taret price for ROIV is USD 18.07 over the next 12 months. The maximum analyst target price is USD 22 while the minimum anlayst target price is USD 12.5.

ROIV stock's Price/Earning ratio is 2.14. Our analysis grades ROIV stock's Price / Earning ratio at D-. This means that ROIV stock's Price/Earning ratio is above 39% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ROIV may be fairly valued for its sector

The last closing price of ROIV's stock was USD 11.97.

The most recent market capitalization for ROIV is USD 8.62B.

Based on targets from 5 analysts, the average taret price for ROIV is projected at USD 18.07 over the next 12 months. This means that ROIV's stock price may go up by +50.97% over the next 12 months.

We can't find any ETFs which contains Roivant Sciences Ltd's stock.

As per our most recent records Roivant Sciences Ltd has 908 Employees.

Roivant Sciences Ltd's registered address is 50 Broadway, London, United Kingdom, SW1H 0DB. You can get more information about it from Roivant Sciences Ltd's website at https://roivant.com.
Loading...